Nitric oxide donors antagonize N-nitro-L-arginine and haloperidol catalepsy: Potential implication for the treatment of parkinsonism?

Polish Journal of Pharmacology

Volumn 49, Issue 4, 1997, Pages 263-266

  Krza̧scik, Paweł ^b   Kostowski, Wojciech ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Catalepsy; Haloperidol; Molsidomine; N nitro L arginine; Nitric oxide

Indexed keywords

ARGININE; HALOPERIDOL; MOLSIDOMINE; N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT;

ANIMALS; ARGININE; CATALEPSY; DISEASE MODELS, ANIMAL; HALOPERIDOL; MALE; MOLSIDOMINE; NITRIC OXIDE SYNTHASE; NITROARGININE; PARKINSON DISEASE; RATS; RATS, WISTAR; VASODILATOR AGENTS;

EID: 1842326779     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Boger R. H., Bode-Borger S. M., Gerecke U., Frolich J. C.: Long term administration of L-arginine, L-NAME and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats. Cardiovasc. Res., 1994, 28, 494-499.
2. Bredt D. S., Snyder S. H.: Nitric oxide: a novel neuronal messenger. Neuron, 1992, 8, 3-11.
3. Bruhwyler J., Chleide E., Liegeois J. F., Carreer F.: Nitric oxide: a new messenger in the brain. Neurosci.. Biobehav. Rev., 1993, 17, 373-384.
4. Garthwaite J., Charles S. L., Chess-Williams R.: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intracellular messenger in the brain. Nature, 1988, 336, 385-388.
5. Jewett D. C., Butelman E. R., Woods J. H.: Nitric oxide synthase inhibitors produce phencyclidine-like behavioral effects in pigeons. Brain Res., 1996, 715, 25-31.
6. Koek W., Woods J. H., Winger G. D.: MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther., 1988, 245, 969-973.
7. Krebs M. O., Desce J. M., Kernel M. L., Gauchy C., Godeheu G., Cheramy A., Glowinski J.: Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem., 1991, 56, 81-85.
8. Lancaster F. E.: Alcohol, nitric oxide and neurotoxicity: is there a connection? - A review. Alcohol. - Clin. Exp. Res., 1992, 16, 539-541.
9. Marietta M. A.: Approaches toward selective inhibition of nitric oxide synthase. J. Med. Chem., 1994, 37, 1899-1907.
10. Morari M., O'Connor W. T., Vangerstedt V., Fuxe K.: N-methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA and glutamate levels in the dorsolateral neostriatum of the halotane-anesthetized rat: an in vivo microdialysis study. J. Neurochem., 1993, 60, 1884-1893.
11. 3H]dopamine uptake. Brain Res., 1994, 641, 83-91.
12. Rondouin G., Bockaert J., Lerner-Natoli M.: L-Nitro-arginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. NeuroReport, 1993, 4, 1187-1190.
13. Tsai M. J., Lee E. H. Y.: Effects of nitric oxide generators on 1-methyl-4-phenyl pyridium-induced toxicity in cultured rat astrocytes. Movement Disord., 1997, 12, Suppl. 1, 40.
14. Writh W. R., Gosswald R., Horein V., Risse K. H.: Zur Pharmakologie acyleter Phenotiazin-Derivate. Arch. Int. Pharmacodyn. Ther., 1958, 115, 1-31.
15. Zu Zhu X., Luo L.G.: Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem., 1992, 59, 932-935.